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p75NTR is a low-affinity nerve growth factor receptor, which promotes cell proliferation as a positive modulator of 
high-affinity receptor TrkA, as well as binds with cell ligands to induce apoptosis and mediate death signals. To analyze the 
regulatory mechanisms of p75NTR, the present study utilized a new membrane yeast two-hybrid system to screen a human fe-
tal brain cDNA library. Results identified BFAR, a novel protein that interacts with p75NTR. Interaction specificity was veri-
fied by membrane yeast two-hybrid co-transformation assays, in vitro GST pull-down assays, and in vitro co-immunopreci- 
pitation assays. The fluorescent subcellular localization assay revealed that the two proteins co-localized within the cytoplasm. 
BFAR overexpression in PC-12 and HEK293T cells inhibited the NFκB and JNK signaling pathway, as determined with the 
luciferase test. Co-transfected p75NTR and BFAR in HEK293T or PC-12 cells, respectively, increased the percentage of cells 
in the G2/M phase, decreased the number of S-phase cells, and did not change the number of G0/G1-phase cells. 
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Nerve growth factor (NGF) is a member of the neurotrophin 
family, which is essential for maintaining proper biological 
functions within the nervous system, by binding specific 
cell surface receptors. NGF has two structurally unrelated 
receptors: tyrosine kinase receptor A (TrkA), which selec-
tively binds to NGF, and p75 neurotrophin receptor 
(p75NTR), which binds all members of the neurotrophin 
family (NGF, BDNF, NT-3, and NT-4/5). The p75NTR 
gene is located at 17q12-17q22. p75NTR belongs to the 
type I single-pass transmembrane glycoprotein, with a mo-
lecular weight of 75 kD. This protein contains a signal pep-
tide, an extracellular domain, a transmembrane domain, and 
an intracellular domain. The extracellular domain contains 
four highly conserved cysteine-rich domains, which serve as 
the ligand binding sites. The intracellular domain has at 
least three domains—the juxtamembrane domain, the type 
II death domain, and the PDZ interaction domain. The jux-
tamembrane domain contains a 29 amino acid sequence 
called the “chopper domain”, which has been implicated in 
neuronal death signaling [1,2]. 
The p75NTR and NGF signaling pathways play an im-
portant role in nervous system development and overall 
health of the nervous system. However, the biological ef-
fects and regulation mechanisms of the pathways remain 
unclear. To detect the p75NTR signaling pathway and to 
analyze nervous disease mechanisms, p75NTR was utilized 
as a bait to screen a human embryonic brain cDNA library 
using the split-ubiquitin membrane yeast two-hybrid system. 
The assay revealed bi-functional apoptosis regulator 
(BFAR), a novel interaction protein of p75NTR. Results 
from the study revealed some biological functions of 
p75NTR and BFAR interactions. 
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1  Materials and methods 
1.1  Reagents, plasmids, and antibodies 
Restriction enzymes were purchased from New England 
Biolabs (Ipswich, Massachusetts, USA); T4 DNA ligase 
and DNA marker were purchased from TaKaRa (Shiga, 
Japan); Pfu enzyme, Taq enzyme, and ssDNA were prod-
ucts of Beijing BioDev-Tech (Beijing, China); PCR product 
clean up kit, DNA fragment gel extraction kit, and plasmid 
extraction kit were purchased from Axygen (Hangzhou, 
China); 3-AT was purchased from Sigma & Aldrich (St. 
Louis, Missouri, USA); DUAL membrane yeast two-hybrid 
system kit, human embryonic brain cDNA library, and the 
HTX β-galactosidase assay kit were purchased from Du-
alsystems Biotech (Schlieren, Switzerland); Isopropyl 
β-D-1-Thiogalactopyranoside (IPTG), protease inhibitor 
cocktails, and Phenylmethanesulfonyl fluoride (PMSF) 
were products of Amresco (Solon, Ohio, USA); Ni-NTA 
agarose beads were purchased from Qiagen (Hilden, Ger-
many); glutathione sepharose 4B beads were purchased 
from Pharmacia Biotech (Stockholm, Sweden). 
DMEM high-glucose medium and fetal bovine serum for 
cell culture were products of Hyclone (Logan, Utah, USA); 
trypsin-EDTA and opti-DMEM were purchased from Gibco 
(Langley, Oklahoma, USA); Lipofectamin™2000 was pur-
chased from Invitrogen (Carlsbad, California, USA); protein 
A+G beads and mouse monoclonal antibody against Myc 
and Flag were purchased from Sigma & Aldrich; rabbit 
monoclonal antibody against p75NTR was purchased from 
Abcam (Cambridge, England); goat anti-rabbit secondary 
antibody-conjugated HRP and rabbit anti-mouse red sec-
ondary antibody-conjugated Cy3 were products of Pro-
teinTech (Chicago, Illinois, USA); rabbit anti-mouse sec-
ondary antibody-conjugated HRP was from Rockland (Gil-
bertsville, Pennsylvania, USA); SuperSigna West Femto 
Maximum Sensitivity Substrate was purchased from Pierce 
(Rockford, Illinois, USA); RNase A was the product of Bei-
jing JingKeHongDa Biotechnology (Beijing, China); pro-
pidium iodide (PI) was purchased from KeyGEN Biotech 
(Shanghai, China); dual luciferase reporter assay system 
was the product of Promega (Fitchburg, Wisconsin, USA). 
The vector pMT18-T used for plasmid construction was 
from TaKaRa; the prokaryotic cell expression vector 
pGEX-5X-1 and pET-28a were from Pharmacia Biotech 
and Novagen (Darmstadt, Germany), respectively; the ani-
mal expression vector pEF-Flag and pCMV-Myc were from 
Invitrogen, and pEGFP-C1 was from Clontech (Mountain 
View, California, USA). The E. coli strains TOP10, BL21, 
and BL21 (DE3), as well as the animal cell lines HEK293T, 
HeLa and PC-12 were maintained in our laboratory. 
1.2  Gene cloning of p75NTR 
According to the gene annotation from Ensembl and Gen-
Bank (accession number: NM_002507), the entire p75NTR 
gene length was 3417 bp and the CDS length was 1284 bp, 
respectively, encoding 427 amino acids, with a total of six 
exons. The first exon was a signal peptide that contained 66 
amino acids. The p75NTR gene was cloned from human 
hepatoma cell line SMMC7721 genomic DNA by amplify-
ing six exons by PCR. Full-length p75NTR was obtained by 
splicing the exons. The amplification primer sequences 
were as follows: Exon1 F: 5′-AGAGGCCATTACGG 
CCATGGGGGCAGGTGCCAC-3′, Exon1 R: 5′-GCACT 
CACCGCTGTGTGTGTACAG-3′; Exon2 F: 5′-CAAGG 
CCATTACGGCCAAGGAGGCATGCCCCAC-3′, Exon2 
R: 5′-CAGAGAATGTCACACTGTCCAGGCAGGGCTC- 
3′; Exon3 F: 5′-AGTGTGACATTCTCTGACGTGGTGA- 
3′, Exon3 R: 5′-CCTCGCACTCGGCGTCGG-3′; Exon4 F: 
5′-CCGACGCCGAGTGCGAGGAGATCCCTGGCCGTT 
G-3′, Exon4 R: 5′-TGTTCCACCTCTTGAAGGCTATGT 
AG-3′; Exon5 F: 5′-TCGAATTCAAGAGGTGGAACAGC 
TGCAAGCAGAA-3′, Exon5 R: 5′-CTTGAGGGCCTGT 
CCCGAGGCTGTCT-3′; Exon6 F: 5′-GGACAGGCCCTC 
AAGGGTGACG-3', Exon6 R: 5′-AGAGGCCGAGGCGG 
CCTCACACCGGGGATGTGG-3′. 
1.3  Screening the interaction protein of p75NTR by 
membrane yeast two-hybrid 
Membrane yeast two-hybrid screen assay was performed 
according to DUAL membrane system manufacturer proto-
cols (Dualsystems Biotech, Switzerland). The system re-
quired that Cub-LexA-VP16-bait and NubG-prey were lo-
cated in the cytosol. Therefore, the p75NTR gene was sub-
cloned into the correct bait vector. To determine whether 
pBT3-SUC-p75NTR was the appropriate bait, a self-acti- 
vation and functional assay were performed. The screening 
conditions were then optimized in a pilot screening, and the 
bait pBT3-SUC-p75NTR was screened against the human 
embryonic brain NubG-fused cDNA library. 
1.4  GST pull-down assay 
p75NTR was cloned into the expression vector pGEX-5X-1 
and transformed into the E. coli strain BL21. The cells were 
incubated in 100 mol L1 IPTG for 2 h at 28C, followed 
by centrifugation and re-suspension in 2 mL PBS. Follow-
ing addition of PMSF and protease inhibitors, the cells were 
sonicated, followed by incubation with 100 L 20% Triton 
X-100 on ice for 30 min. The protein was then purified 
through glutathione-sepharose 4B beads (Invitrogen). 
Full-length BFAR was cloned into the vector pET-28a and 
expressed in the E. coli strain BL21 (DE3), followed by 
incubation with 100 mol L1 IPTG for 6 h at 22C. After 
the cells were collected by centrifugation and re-suspended 
in 2 mL Ni-lysis buffer (50 mmol L1 sodium phosphate, 
300 mmol L1 NaCl, 10 mmol L1 imidazole, pH 8.0), the 
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cells were sonicated and purified by Ni-NTA agarose (Qi-
agen), the beads were washed three times with 200 L wash 
buffer (50 mmol L1 sodium phosphate, 300 mmol L1 NaCl, 
20 mmol L1 imidazole, pH 8.0), and the protein was eluted 
with 60 L elution buffer (50 mmol L1 sodium phosphate, 
300 mmol L1 NaCl, 250 mmol L1 imidazole, pH 8.0). The 
two purified proteins were incubated in 500 L NETN 
buffer (100 mmol L1 NaCl, 1 mmol L1 EDTA, 20 mmol 
L1 Tris-HCl, 0.5% Nonidet P-40, 1 mmol L1 PMSF, pH 
7.0) at 4°C for 4–8 h, and the beads washed three times with 
buffer H (20 mmol L1 HEPES, 50 mmol L1 KCl, 20% 
glycerol, 0.1% Nonidet P-40, 0.007% β-mercaptoethanol, 
pH 7.7). The protein-bound beads were subjected to West-
ern blot analysis with mouse anti-His antibody (Sigma). 
1.5  Co-immunoprecipitation assay 
p75NTR was cloned into the vector pEF-Flag, and 
full-length BFAR was cloned into the vector pCMV-Myc. 
The two plasmids were co-transfected into PC-12 cells with 
Lipofectamin 2000. The cells were incubated at 37°C in 5% 
CO2 for 36–48 h, then collected and washed in ice-cold PBS, 
followed by the addition of 1 mL lysis buffer. A total of 40 
L lysis supernatant was used for Western blot analysis of 
plasmid expression level. The cell lysates were pre-cleared 
with protein A/G agarose beads for 1 h at 4C, then im-
munoprecipitated with 2 g relative antibody at 4°C for 1 h 
and incubated in 20 L protein A/G agarose at 4C over-
night. The immunoprecipitated agarose was washed three 
times in ice-cold PBS, then subjected to SDS-PAGE and 
Western blot analysis using anti-Myc or anti-p75NTR anti-
bodies. 
1.6  Immunofluorescence imaging of HeLa cells 
Full-length BFAR was cloned into the vector pEGFP-C1 
and transiently co-transfected into HeLa cells with 
pEF-Flag-p75NTR. Following incubation at 37°C in 5% 
CO2 for 2436 h, the cells were fixed in 4% paraformalde-
hyde for 1 h, permeabilized in 1% Triton X-100 for 10 min, 
blocked in 1% bovine serum albumin for 1 h, and incubated 
in anti-p75NTR antibody used at a 1/200 dilution at 4C 
overnight. The cells were then washed five times in PBST, 
incubated in goat anti-rabbit-Cy3 antibody at a 1/500 dilu-
tion for 1 h, washed five times with PBST, and stained with 
1 g mL1 Hoechst 33542 for 10 min. The cells were then 
analyzed by fluorescence microscopy (Zeiss) (green fluo-
rescent at 480 nm and red fluorescence at 568 nm). 
1.7  Luciferase activity assay 
Cells were digested in 0.05% trypsin and cultured in 
24-well plates at a density of 2×105 cells mL1 one day prior 
to transfection. The signal pathway reporter plasmid 
(p53-luc, NFκB-luc, CRE-luc, SRE-luc, or AP1-luc), inter-
nal reference plasmid Rellina, and the plasmid of interest or 
empty control plasmid were co-transfected into the cells. 
Following incubation at 37°C in 5% CO2 for 48 h, the cells 
were lysed in Passive Lysis Buffer (PLB) according to the 
Promega dual luciferase reporter assay system protocol. 
Luciferase activity was measured by luminescence. Each 
test required 5 L of cell lysis supernatant, with 25 L 
LARII to determine firefly luciferase activity, and 25 L 
Stop & Glo substrate solution for Rellina luciferase activity. 
Each sample was analyzed in triplicate. 
1.8  Cell cycle assay 
The cells were digested in 0.05% trypsin, washed two times 
in PBS, fixed in ice-cold 75% ethanol at 4°C overnight, and 
washed two times in PBS. The cells were then re-suspended 
in 400 L PBS and incubated in 4 L PI(1 mg mL1) and 10 
L RNaseA (10 mg mL1) in darkness for 10 min at room 
temperature. The cells were then filtered through a 200 µm 
mesh nylon membrane, and cell cycle analysis was analyzed 
by FACS. Each experiment was repeated in triplicate. 
2  Results 
2.1  Identification of potential interactional proteins of 
p75NTR using the membrane yeast two-hybrid system 
Because p75NTR was a type-I membrane protein, the dual 
membrane yeast two-hybrid system was utilized to identify 
further interactional proteins. For the self-activation and 
functional assay, the bait pBT3-SUC-p75NTR was 
co-transformed with pOst1-NubI and the empty library 
vector pPR3-N into the yeast strain NMY51, respectively. 
The transformed yeast cells were streaked onto SD-trp-leu 
(SD-TL), SD-trp-leu-his (SD-TLH), and SD-trp-leu-his-ade 
(SD-TLHA) selection plates and incubated for 3 d at 30°C, 
respectively. pTSU2-APP/ pNubG-Fe65 was used as a posi-
tive control and pTSU2- APP/pPR3-N as a negative control. 
Results showed that the co-transformation of p75NTR with 
pPR3-N did not grow on SD-TLH and SD-TLHA selection 
plates, demonstrating that p75NTR exhibited no self-acti- 
vation activity (Table 1). However, co-transformation of 
p75NTR and pOst1-NubI did grow on SD-TLH and 
SD-TLHA selection plates, suggesting that HIS3 and ADE2 
reporter genes were activated (Table 1). Subsequently, a 
human fetal brain cDNA library was transformed into 
NMY51-expressing p75NTR, and the interactors were se-
lected using stringency conditions on SD-TLHA containing 
1 mmol L1 3-AT plates. A total of 89 positive clones were 
obtained from 3.9×105 transformants, all of which be-
longed to 38 genes, according to BLAST analysis. One of 
the positive clones encoded BFAR (bifunctional apoptosis 
regulator). To confirm the interaction between p75NTR and  
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Table 1  p75NTR functional assay results, p75NTR self-activation and 
functional assay results. Data represent clone growth on the selection plate 
Self-activation and functional assay SD-TL SD-TLH SD-TLHA 
pBT3-SUC-p75NTR/pOst1-NubI 810 151 64 
pBT3-SUC-p75NTR/pPR3-N 809 1 2 
PTSU2-APP/pNubG-Fe65(+) 670 400 350 
PTSU2-APP/pPR3-N() 650 2 0 
 
BFAR, full-length BFAR cDNA was cloned into the prey 
vector pPR3-N and co-transformed with pBT3-SUC- 
p75NTR into NMY51 strain cells. The resulting co-trans- 
formant was assayed for growth on the same selective me-
dium that was used in the library screen, as well as for color 
formation in the β-galactosidase assay. Results showed that 
all reporter genes were active, but the negative control did 
not exhibit β-galactosidase activity (Figure 1). 
2.2  p75NTR interacts with BFAR in vitro 
To exclude false positives in the yeast cultures, GST pull- 
down assays were employed to verify interactions between 
p75NTR and BFAR. Results showed that the GST protein 
did not bind to BFAR (Figure 2, line 2), but the GST-  
 
 
Figure 1  Yeast two-hybrid interactions between p75NTR and BFAR. 
pBT-SUC-p75NTR/pPR3-N-BFAR were co-transformed into the yeast 
strain NMY51, and the HTX β-galactosidase assay was performed to 
measure reaction absorbance at 0.5, 1.5, 2.5, and 4.5 h. An A615/A546 ra-
tio>1.0 represents lacZ activity, but <1.0 represents inactivity. “+”, positive 
control pTSU2-APP/pNubG-Fe65; “”, negative control pBT3-SUC-  
p75NTR/pPR3-N. 
 
Figure 2  In vitro GST pull-down assay. Line 1, pET-28a-BFAR input; 
line 2, pGEX-5X-1 empty vector and pET-28a-BFAR expression; lines 3 
and 4, pGEX-5X-1-p75NTR and pET-28a-BFAR expression, respectively. 
p75NTR protein bound to the BFAR protein in vitro (Figure 
2, lines 3 and 4), demonstrating that the two proteins di-
rectly interacted in vitro. 
2.3  p75NTR interacts with BFAR in vitro 
To assess whether p75NTR interacted with BFAR, PC-12 
cells were transiently co-transfected with pEF-Flag- 
p75NTR and pCMV-Myc-BFAR, or with pEF-Flag- 
p75NTR and pCMV-Myc as the negative controls, respec-
tively. Following 48-h incubation, whole lysates were sub-
jected to immunoprecipitation with anti-p75NTR or an-
ti-Myc antibody. Results showed that p75NTR was recog-
nized by the Myc-BFAR immunoprecipitates (Figure 3, line 
2), but Myc was not recognized (Figure 3, line 1), which 
suggested that p75NTR specifically co-immunoprecipitated 
with BFAR.  
2.4  p75NTR and BFAR co-localized in HeLa cells 
To further examine the interaction between p75NTR    
and BFAR in living cells, pEGFP-C1-BFAR and pEF-    
Flag-p75NTR were transfected, respectively, or co-trans- 
fected into HeLa cells, followed by immunofluorescence 
co-localization using confocal fluorescence microscopy. 
Results demonstrated that BFAR was localized in the cyto-
plasm (green) when expressed alone, and p75NTR was ex-
pressed in the cell cytoplasm and cell membrane (red). 
However, when co-expressed, p75NTR and BFAR co-  
localized to the cytoplasm (orange) (Figure 4). These results 
suggested that p75NTR physically interacted with BFAR  
in vitro. 
2.5  p75NTR and BFAR interaction effects on signal 
pathway  
p75NTR-mediated apoptosis has been widely reported [3,4].  
 
 
Figure 3  Co-immunoprecipitate assay in vitro. Line 1, pEF-Flag- 
p75NTR and pCMV-Myc co-transfected into PC-12 cells; line 2, pEF- 
Flag-p75NTR and pCMV-Myc-BFAR co-transfected into PC-12 cells. 
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Figure 4  Co-localization of p75NTR and BFAR in HeLa cells. AC, pEGFP-C1-BFAR transfected into HeLa cells alone. DF, pEF-Flag-p75NTR trans-
fected into HeLa cells alone; cells were analyzed using immunofluorescence. GJ, pEF-Flag-p75NTR and pEGFP-C1-BFAR co-transfected into HeLa cells.  
The right images (C, F, and J) show merged images from the two left images, respectively. 
In addition, p75NTR plays an important role in the regula-
tion of cell cycle and -amyloid formation [5,6]. Previous 
studies have shown that NFκB, JNK, p53, ceramide, and 
other molecules are involved in p75NTR apoptotic signal 
transduction [7–11]. BFAR is a dual-functional apoptosis 
regulator [12]. To determine whether interactions between 
BFAR and p75NTR affected p75NTR-mediated apoptosis 
signal transduction, the dual luciferase assay system 
(Promega) was used to detect the effect of BFAR on four 
reporter genes from the NFκB and JNK signaling pathways 
in PC-12 and HEK293T cells, respectively (Table 2). 
pCMV-Myc-BFAR or empty vector pCMV-Myc, reporter 
plasmid, and TP-Rellina were co-transfected into PC-12 
cells. Following 48-h incubation, the cells were lysed with 
PLB, and lysis supernatant luciferase activity was measured 
by luminescence. Results demonstrated that BFAR sup-
pressed NFκB, AP1, SRE, and CRE reporter gene transcrip-
tional activity in PC-12 cells. Compared with the empty 
plasmid group, all four signaling pathways were inhibited 
after transfection with pCMV-Myc-BFAR, and luciferase 
activity decreased by 48.67%, 31.41%, 22.19%, and 28.04%, 
respectively (Figure 5A). In contrast, pCMV-Myc-BFAR 
and pEF-Flag-p75NTR were co-transfected into HEK293T 
cells, meanwhile, the empty vector pCMV-Myc were 
co-transfected with pEF-Flag-p75NTR as the negative con-
trols, demonstrating that BFAR and p75NTR inhibited 
NFκB, AP1, SRE, and CRE activity to varying degrees in 
HEK293T cells, respectively (Figure 5B). 
2.6  BFAR over-expression affects the cell cycle  
Suppression of p75NTR expression in PC-12 cells has been 
shown to induce up-regulation of cyclin D2 [5]. In addition, 
over-expression of BFAR impacts multiple signaling path-
ways in PC-12 cells to varying degrees. To determine 
whether BFAR affects the cell cycle, PC-12 cells were tran-
siently transfected with pCMV-Myc-BFAR or pCMV-Myc, 
respectively. As shown in Figure 6A, the percentage of cells 
at S phase was less in BFAR-PC-12 cells (17.15%) than in 
Vec-PC-12 cells (25.57%), while the percentage of cells at 
the G2/M phase was greater in BFAR-PC-12 cells (14.82%) 
than in Vec-PC-12 cells (10.49%). However, the percentage 
of cells at the G0/G1 phase remained unchanged (68.05% in 
BFAR-PC-12 cells and 64.74% in Vec-PC-12 cells). Simi-
lar results were also demonstrated in BFAR-HEK293T cells, 
as shown in Figure 6B. The percentage of cells in the S 
phase was less in BFAR-HEK293T cells (28.71%) than in 
Vec-HEK293T cells (37.85%), while the percentage of cells 
in the G2/M phase was greater in BFAR-HEK293T cells  






pathways Enhancer element 
Activator Protein 1 AP1 c-jun/c-fos JNK 
Nuclear factor of κB cells NFκB NFκB NFκB 
Serum response element SRE Elk-1/SRF MAPK/JNK 
cAMP response element CRE ATF2/CREB JNK/p38&PKA 
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Figure 5  BFAR inhibits NFκB, AP1, SRE, and CRE signal pathway activity. A, BFAR individually inhibits all four signal pathways in PC-12 cells. B,  
Co-transfected p75NTR and BFAR inhibit activity in all four signal pathways in HEK293T cells. 
 
Figure 6  BFAR over-expression affects cell cycle, as determined by flow cytometry. A, pCMV-Myc-BFAR and pCMV-Myc were transfected into PC-12  
cells, respectively. B, pCMV-Myc-BFAR and pCMV-Myc were transfected into HEK293T cells, respectively. 
(28.82%) than in Vec-HEK293T cells (22.19%). In addition, 
the percentage of cells in the G0/G1 phase was 42.47% and 
49.96%, respectively. These results suggested that BFAR 
over-expression significantly affected cell proliferation. 
3  Discussion 
As a transmembrane protein, the low-affinity receptor 
p75NTR is widely expressed in tissues and tumor cells of 
the nervous and non-nervous systems, and is also up-regu- 
lated following injury. p75NTR promotes cell survival as a 
co-receptor for TrkA-mediated death signals, and p75NTR 
death signaling closely correlates with a number of human 
neurodegenerative diseases, such as Alzheimer’s disease 
and motor neuron disease [1,2,13,14]. Therefore, there is a 
need for a better understanding of p75NTR protein interac-
tions, as well as the physiological and pathological molecu-
lar mechanisms of action.  
Yeast two-hybrid technology is an efficient method for 
studying protein-protein interactions within living cells, and 
a number of proteins have been identified to interact with 
p75NTR using this technology [15–18]. However, the con-
ventional yeast two-hybrid system has limitations for stud-
ying membrane-protein interactions. First, the conventional 
two-hybrid assay requires that bait and prey proteins must 
be targeted to the nucleus. Therefore, only the intracellular 
domain of membrane proteins can be identified using this 
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approach. Second, the captured target proteins are primarily 
intracellular soluble proteins, rather than membrane-asso- 
ciated proteins. 
The DUAL membrane system is a yeast-based screening 
assay, which takes advantage of the split-ubiquitin system 
developed by Johnsson and Varshavsky to detect interac-
tions between integral membrane proteins, mem-
brane-associated proteins, and soluble proteins in their nat-
ural setting [19]. In the present study, the DUAL membrane 
system was utilized to screen a human fetal brain cDNA 
library with p75NTR as the bait to identify the interacting 
partner BFAR. The protein interaction was further con-
firmed using the GST pull-down in vitro assay, as well as in 
vitro co-immunoprecipitation, and subcellular co-localiza- 
tion experiments. 
The BFAR gene encodes a protein composed of 450 
amino acids, which contains four recognizable domains 
[20,21]. These domains include an N-terminal zinc-binding 
RING domain for binding ubiquitin conjugating enzymes 
(E2s), a SAM domain that interacts with Bcl-2 and Bcl-XL 
and suppresses Bax-induced cell death, a DED-like domain 
for blocking activation of the Fas-induced apoptosis path-
way, and a C-terminal transmembrane (TM) domain that 
enables BFAR to insert into the endoplasmic reticulum 
membrane. Immunoblot analysis of normal human tissues 
has shown that BFAR is highly expressed in the brain [12]. 
In addition, endogenous BFAR expression is reduced under 
prolonged ER stress [22]. 
p75NTR and BFAR are integrated membrane proteins. 
p75NTR is synthesized in the endoplasmic reticulum and 
then transferred to the plasma membrane, while BFAR is 
primarily localized in the endoplasmic reticulum [12]. 
Therefore, the two proteins are in close proximity to each 
other, allowing for interactions within the endoplasmic re-
ticulum or cytoplasm, which was confirmed by immunoflu-
orescence analysis from the present study. It has been re-
ported that HIP1, Hippi, and Bap31 all contain a pseu-
do-DED domain, which interacts with BFAR [12]. p75NTR 
also contains an analogous DD domain, which might be the 
structure that mediates interactions between BFAR and 
p75NTR.  
Previous studies have shown that NFκB and JNK signal-
ing correlate with p75NTR-mediated apoptosis [7–11,23,24]. 
In addition, BFAR has been shown to suppress cell apopto-
sis, although p75NTR, as a NGF receptor, induces cell 
apoptosis [25,26]. The functional antagonism could indicate 
that BFAR inhibited p75NTR-mediated cell apoptosis. In 
the present study, p75NTR and BFAR co-transfection into 
PC-12 or HEK293T cells resulted in inhibition of NFκB- 
and JNK-related signal pathways, as determined by the lu-
ciferase reporter test. However, the physiological signifi-
cance of BFAR inhibition on these signaling pathways re-
mains to be shown. 
Although the pathological features of neurodegenerative 
diseases have been well-studied, effective therapeutics re-
main limited, primarily because the regulatory mechanisms 
of neuronal cell survival and death remain unclear. In sum-
mary, results from the present study demonstrated specific 
protein-protein interactions between p75NTR and BFAR, as 
well as interaction effects on the p75NTR-mediated signal-
ing pathway and cell cycle in PC-12 and HEK293T cells. 
Future studies of the effects of p75NTR and BFAR interac-
tions on neuroprotection regulation are necessary to better 
understand neuronal survival and death regulatory mecha-
nisms, as well as to provide new methods for treating neu-
rodegenerative diseases. 
We thank Prof. Shen AiGuo and Dr. Tao Tao for helpful discussion. We 
thank Dr. Luo ShiPing for technical assistance. This work was supported 
by the National High Technology Research and Development Program   
of China (Grant No. 2006AA02A310), National Science and Technology 
Key Program of China (Grant Nos. 2008ZX10003-006 and 2009ZX09301- 
011) and National Basic Research Program of China (Grant No. 
2010CB912609) which were awarded to Huo KeKe. 
1 Coulson E J, Reid K, Baca M, et al. Chopper, a new death domain of 
the p75 neurotrophin receptor that mediates rapid neuronal cell death. 
J Biol Chem, 2000, 275: 30537–30545 
2 Clare K U, Elizabeth J C. The p75 neurotrophin receptor. Int J Bio-
chem Cell Biol, 2008, 40: 1664–1668 
3 Rabizadeh S, Oh J, Zhong L, et al. Induction of Apoptosis by the 
low-affinity NGF receptor. Science, 1993, 261: 345–348 
4 Salehi A H, Roux P P, Kubu C J, et al. NRAGE, a novel MAGE pro-
tein, interacts with the p75 neurotrophin receptor and facilitates nerve 
growth factor-dependent apoptosis. Neuron, 2000, 27: 279–288 
5 Fritz M D, Mirnics Z K, Nylander K D, et al. p75NTR enhances 
PC-12 cell tumor growth by a non-receptor mechanism involving 
downregulation of cyclin D2. Exp Cell Res, 2006, 312: 3287–3297 
6 Wang Y J, Wang X, Lu J J, et al. p75NTR regulates Abeta deposition 
by increasing Abeta production but inhibiting Abeta aggregation with 
its extracellular domain. J Neurosci, 2011, 31: 2292–2304 
7 Carter B D, Kaltschmidt C, Kaltschmidt B, et al. Selective activation 
of NF-kappa B by nerve growth factor through the neurotrophin re-
ceptor p75. Science, 1996, 272: 542–545 
8 Khursigara G, Orlinick J R, Chao M V. Association of the p75 neu-
rotrophin receptor with TRAF6. J Biol Chem, 1999, 274: 2597–2600  
9 Bhakar A L, Howell J L, Paul C E, et al. Apoptosis induced by 
p75NTR overexpression requires Jun kinase-dependent phosphoryla-
tion of Bad. J Neurosci, 2003, 23: 11373–11381 
10 Yoon S O, Bonnefil C P, Carter B, et al. Competitive signaling be-
tween TrkA and p75 nerve growth factor receptors determines cell 
survival. J Neurosci, 1998, 18: 3273–3281 
11 Gentry J J, Bonnefil C P, Carter B D. Nerve growth factor activation 
of nuclear factor kappa B through its p75 receptor is an anti-apoptotic 
signal in RN22 schwannoma cells. J Biol Chem, 2000, 275: 
7558–7565 
12 Roth W, Kermer P, Krajewskal M, et al. Bifunctional apoptosis in-
hibitor (BAR) protects neurons from diverse cell death pathways. 
Cell Death Differ, 2003, 10: 1178–1187 
13 Dechant G, Barde Y A. The neurotrophin receptor p75NTR: Novel 
functions and implications for diseases of the nervous system. Nat 
Neurosci, 2002, 5: 1131–1136 
14 José M F, Noelia L S. A novel hypothesis for Alzheimer disease 
based on neuronal tetraploidy induced by p75NTR. Cell Cycle, 2010, 
9: 1934–1941 
15 Mukai J, Hachiya T, Hoshino S S, et al. NADE, a p75NTR-     
associated cell death executor, is involved in signal transduction me-
diated by the common neurotrophin receptor p75NTR. J Biol Chem, 
2000, 275: 17566–17570 
374 Li H M, et al.   Sci China Life Sci   April (2012) Vol.55 No.4 
16 Bai D, Chen H, Huang B. RanBPM is a novel binding protein for 
p75NTR. Biochem Biophys Res Commun, 2003, 309: 552–557 
17 Nichols A, Martinou I, Maundrell K, et al. The p75 neurotrophin  
receptor: effects on neuron survival in vitro and interaction with 
death domain-containing adaptor proteins. Apoptosis, 1998, 3: 289– 
294 
18 Roxana P, Melinda B, James D D, et al. Sall2 is a novel 
p75NTR-interacting protein that links NGF signalling to cell cycle 
progression and neurite outgrowth. EMBO J, 2009, 28: 261–273 
19 Johnsson N, Varshavsky A. Split ubiquitin as a sensor of protein in-
teractions in vivo. Proc Natl Acad Sci USA, 1994, 91: 10340–10344 
20 Zhang H, Xu Q, Stanislaw Krajewski, et al. BAR: an apoptosis regu-
lator at the intersection of caspases and Bcl-2 family proteins . Proc 
Natl Acad Sci USA, 2000, 97: 2597–2602 
21 Chu C C, Gao J P, Ho Y S. Over-expression of a modified bifunc-
tional apoptosis regulator protects against cardiac injury and doxoru-
bicin-induced cardiotoxicity in transgenic mice. Cardiovasc Res, 
2009, 81: 20–27 
22 Rong J, Chen L L, Toth J I, et al. Bifunctional apoptosis regulator 
(BAR), an endoplasmic reticulum (ER)-associated E3 ubiquitin ligase, 
modulates BI-1 protein stability and function in ER stress. J Biol 
Chem, 2011, 286: 1453–1463 
23 Ye X, Mehlen P, Rabizadeh S, et al. TRAF family proteins interact 
with the common neurotrophin receptor and modulate apoptosis in-
duction. J Biol Chem, 1999, 274: 30202–30208 
24 Bai Y, Li Q, Yang J, et al. p75NTR activation of NF-κB is involved 
in PrP106-126-induced apoptosis in mouse neuroblastoma cells. 
Neurosci Res, 2008, 62: 9–14 
25 Andrea C, Elisabetta P, Anton J H, et al. Neurotrophin p75 Receptor 
(p75NTR) promotes endothelial cell apoptosis and inhibits angiogene-
sis: implications for diabetes-induced impaired neovascularization in 
ischemic limb muscles. Circ Res, 2008, 103: e15–e26 
26 Küchler J, Hartmann W, Waha A, et al. p75(NTR) induces apoptosis 
in medulloblastoma cells. Int J Cancer, 2011, 128: 1804–1812 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
